1289 results about "Radioactive agent" patented technology

A radioactive material detection apparatus includes a transmitter, a radiation sensor and a controller. The transmitter is capable of transmitting information in correspondence with a signal. The radiation sensor has a sensor output and is configured to detect radiation over a predetermined period of time. The controller is configured to receive the sensor output from the radiation sensor and to send the signal to the transmitter for transmission.

A surgical fastening system, utilizing surgical clips made from bio-absorbable materials, for use in the rapid closing of deep internal wounds in humans or animals is disclosed. Elements of the system include surgical clips, applicators of surgical clips and dispensers of surgical clips. The surgical clips may contain small amounts of prophylactic antibiotic medication, long-acting time-release pain medication, radio-opaque markers, small amounts of radioactive material, colors, and/or patterns.

A method and apparatus for transporting syringes containing radioactive material. The apparatus includes a radiopharmaceutical pig having an inner chamber in which a sharps container can be secured. The sharps container has a housing and an attachable cap. The method includes assembling the radiopharmaceutical pig so that the chamber of the radiopharmaceutical pig contains the syringe in the sharps container housing. The radiopharmaceutical pig is disassembled, where upon the syringe is removed, discharged, and then replaced in the sharps container housing. The cap of the sharps container is affixed to the housing of the sharps container, thus enclosing the contaminated syringe therein. The radiopharmaceutical pig is assembled so that its chamber contains the sharps container and the syringe. The radiopharmaceutical pig is transported to a disposal area, where it is disassembled and the sharps container containing the syringe is placed in a particular disposal container.

A system and method for identifying, reporting, and evaluating a presence of a solid, liquid, gas, or other substance of interest, particularly a dangerous, hazardous, or otherwise threatening chemical, biological, or radioactive substance. The system comprises one or more substantially automated, location self-aware remote sensing units; a control unit; and one or more data processing and storage servers. Data is collected by the remote sensing units and transmitted to the control unit; the control unit generates and uploads a report incorporating the data to the servers; and thereafter the report is available for review by a hierarchy of responsive and evaluative authorities via a wide area network. The evaluative authorities include a group of relevant experts who may be widely or even globally distributed.

The present invention provides novel adenosine receptor antagonists, more particularly, A₁ adenosine receptor antagonists. Pharmaceutical compositions comprising an A₁ adenosine receptor antagonist disclosed herein and a pharmaceutically acceptable carrier are further provided. Compositions also include diagnostic assay-type probes comprising a novel A₁ adenosine receptor antagonist that is labeled or conjugated with radioactive or non-radioactive material. Methods for treating A₁ adenosine receptor related disorders comprising administering an A₁ adenosine receptor antagonist of the invention are also disclosed. The novel A₁ adenosine receptor antagonist compositions find further use in diagnostic and imaging methods.

A new transmutation assembly permits an efficient transmutation of a long-lived radioactive material (long-lived FP nuclides such as technetium-99 or iodine-129) which was produced in the nuclear reactor. Wire-type members of a long-lived radioactive material comprised of metals, alloys or compounds including long-lived FP nuclides are surrounded by a moderator material and installed in cladding tubes to form FP pins. The FP pins, and nothing else, are housed in a wrapper tube to form a transmutation assembly. The wire-type members can be replaced by thin ring-type members. The transmutation assemblies can be selectively and at least partly loaded into a core region, a blanket region or a shield region of a reactor core in a fast reactor. From a viewpoint of reducing the influence on the reactor core characteristics, it is optimal to load the transmutation assemblies into the blanket region.

A radioactive material detection system includes a cargo container monitoring system and a control center. The cargo container monitoring system has a radiation sensor configured to detect radiation over a predetermined or commanded period of time and a transceiver configured to send the information received from the radiation sensor. The control center is in communication with the transceiver of the cargo container monitoring system. The control center is configured to receive data from at least one additional source other than the cargo container monitoring system and to asynchronously analyze the data from the at least one additional source and the information from the radiation sensor, during transit, so as to detect radioactive material in a cargo container.

In the present invention there is a provided an array of radiation detectors comprising at least one detector capable of detecting both low and high energy gamma radiation and adapted to provide spectrometric identification of the gamma source; at least one detector capable of detecting and providing spectrometric identification of fast neutrons and low resolution gamma spectra; at least one detector adapted to detect thermal neutrons; and, at least one plastic scintillator to give enhanced gamma ray sensitivity.

A method and apparatus for marking a lesion in a body part is provided. The method includes the steps of obtaining a first nuclear-emission image of the body part; determining a position of the lesion from the first image; percutaneously introducing a cannula to the determined position; inserting a wire into the cannula, the wire including radioactive material; retracting the cannula while holding the wire in place; and obtaining a second nuclear-emission image of the body part. The second image includes data relating to a position of the lesion and data relating to a position of the wire.

The invention relates to an active-passive combined reactor core residual heat removal system for a nuclear power station. The active-passive combined reactor core residual heat removal system comprises a safety injection system, a containment spraying system, an auxiliary water supply system, a reactor cavity water injection system, a secondary side passive residual heat removal system, a passive containment heat leading-out system and related valves and pipelines. The active-passive combined reactor core residual heat removal system provided by the invention realizes three safety functions of controlling reactivity, discharging reactor core heat and containing radioactive substance when an accident occurs in an active-passive combined multi-redundancy diversity manner. The active-passive combined reactor core residual heat removal system provided by the invention can completely realize the safety functions of safety injection and safety spraying under the condition that the accident occurs in a nuclear power plant, reactor cavity water injection under the serious accident working condition and the like, effectively improve reliability of a safety system, enhance coping capability of the safety system under the working condition that the accident occurs in the nuclear power station, can effectively prevent and relieve the serious accident, reduce the reactor core melting probability and risk probability of large-scale radioactivity release and greatly improve safety performance of the nuclear power station.

A bioabsorbable brachytherapy device includes a tubular housing with sealed ends and an enclosed radioactive material. The radioactive material includes a radioisotope, such as palladium-103 or iodine-125. The tubular housing is made from a biocompatible and bioabsorbable polymeric material, and is sealed by means such as heat welding or solvent fixing. The device may further include a radiopaque medium and one or more therapeutic drugs.

An ocular brachytherapy device, generally comprising a catheter and wire, impregnated with radioactive material, are provided. The wire is formed having a desired treatment shape and size such that it can be placed near an area requiring treatment and effectuate treatment while not affecting adjacent areas. For ease in placement near such areas the wire is preferably formed using materials having properties that permit formation into a desired shape while allowing the wire to be straightened for retraction into the catheter, the shape returning upon removal from the catheter. The wire is preferably impregnated with radioactive material. When the catheter is placed near the area of treatment and the wire is pushed out of the catheter, the wire retakes the desired form and provides a therapeutic radioactive treatment to the area. Preferably, the radioactive material is placed on one edge of the wire, such that the radiation can be directed to the affected area, and non-affected areas can be shielded from radiation.

A system and method for identifying, reporting, and evaluating a presence of a solid, liquid, gas, or other substance of interest, particularly a dangerous, hazardous, or otherwise threatening chemical, biological, or radioactive substance. The system comprises one or more substantially automated, location self-aware remote sensing units; a control unit; and one or more data processing and storage servers. Data is collected by the remote sensing units and transmitted to the control unit; the control unit generates and uploads a report incorporating the data to the servers; and thereafter the report is available for review by a hierarchy of responsive and evaluative authorities via a wide area network. The evaluative authorities include a group of relevant experts who may be widely or even globally distributed.

The invention provides a radioactive substance detection method, a radioactive substance detection device and a radioactive substance detection system based on a gamma camera. The detection method comprises the following steps of: receiving gamma photons incident from all directions of a target angle plane (alpha, beta) defined by radioactive substances by using the gamma camera; generating gamma photon energy spectrums and projection data of the radioactive substances; and reconstructing the projection data by using a 'maximum likelihood estimation' statistical iterative algorithm to obtain a gamma radiation image with quantitative information. By the method, the spatial resolution and the signal to noise ratio of the gamma radiation image are increased, spaces of the radioactive substances are positioned, the radiation dose is measured, nuclide types of the radioactive substances are identified, and the radioactive activity is measured.

The invention relates to a composite shielding material and a preparation method thereof, in particular to the composite shielding material applied to nuclear radiation places such as nuclear reactor, spent fuel assembly storage and radioactive substance storage and transportation and the like. The composite shielding material is characterized by comprising the following components in percentage by weight: 0 to 30 percent of w and compound thereof, 0 to 70 percent of B4C, 0 to 90 percent of aluminum or aluminum alloy, 0 to 8 percent of other elements and the like. The composite shielding material comprising tungsten B4C/aluminum alloy is uniform in distribution of W2B5 and B4C, high in densification degree, high in strength and toughness, and particularly applicable to the field of neutron/gamma ray shielding.

The present invention provides methods and compositions related to the fields of chemoinformatics, chemogenomics, drug discovery and development, and drug targeting. In particular, the present invention provides subcellular localization signals (e.g., chemical address tags) that influence (e.g., direct) subcellular and organelle level localization of associated compounds (e.g., drugs and small molecule therapeutics, radioactive species, dyes and imagining agents, proapoptotic agents, antibiotics, etc) in target cells and tissues. The compositions of the present invention modulate the pharmacological profiles of associated compounds by influencing the compound's accumulation, or exclusion, from subcellular loci such as mitochondria, endoplasmic reticulum, cytoplasm, vesicles, granules, nuclei and nucleoli and other subcellular organelles and compartments. The present invention also provides methods for identifying chemical address tags, predicting their targeting characteristics, and for rational designing chemical libraries comprising chemical address tags.

The invention relates to reactor design technology, in particular to a passive heat removal device for dealing with a station blackout accident. The passive heat removal device structurally comprises a secondary side passive residual heat removal system and a passive containment heat export system, and the secondary side passive residual heat removal system is used for exporting residual heat of a reactor core and sensible heat of various devices of a reactor coolant system, so that a reactor is maintained to be in a safe shutdown state. The passive containment heat export system is used for exporting heat in a containment released by the reactor core so as to maintain integrity of the containment. The secondary side passive residual heat removal system and the passive containment heat export system share a hot water tank. The passive heat removal device for dealing with the station blackout accident is capable of exporting decay heat of the reactor core and heat in containment space released by the reactor core under the working condition of the station blackout accident, and melting probability of the reactor core and probability of radioactive substances released to the environment are evidently lowered.